Paper41345965
Evaluation of the safety and immunogenicity of a peptide vaccine against canine leishmaniosis: a double-blind, multicenter, controlled clinical trial in dogs.
Hurtado-Morillas C and 6 others. Vet Q, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Evaluation of the safety and immunogenicity of a peptide vaccine against canine leishmaniosis: a double-blind, multicenter, controlled clinical trial in dogs. Papers, record 41345965. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41345965
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluation of the safety and immunogenicity of a peptide vaccine against canine leishmaniosis: a double-blind, multicenter, controlled clinical trial in dogs.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dog Diseases | Major topic |
| Leishmania infantum | Major topic |
| Leishmaniasis, Visceral | Major topic |
| Leishmaniasis Vaccines | Major topic |
| Animals | |
| Dogs | |
| Double-Blind Method | |
| Female | |
| Male | |
| Vaccines, Subunit | |
| Immunogenicity, Vaccine | |
| Antibodies, Protozoan | |
| Protein Subunit Vaccines |
Source PubMed
References64
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37631952 | Intramuscular Immunization with a Liposomal Multi-Epitope Chimeric Protein Induces Strong Cellular Immune Responses against Visceral Leishmaniasis. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37631952 | PubMed |
| 2 | 37251529 | Advances in Computational and Bioinformatics Tools and Databases for Designing and Developing a Multi-Epitope-Based Peptide Vaccine. | Int J Pept Res Ther | 2023 | https://conductscience.org/library/papers/37251529 | PubMed |
| 3 | 34089789 | Potential of TLR agonist as an adjuvant in Leishmania vaccine against visceral leishmaniasis in BALB/c mice. | Microb Pathog | 2021 | https://conductscience.org/library/papers/34089789 | PubMed |
| 4 | 29027520 | Further evidence associating IgG1, but not IgG2, with susceptibility to canine visceral leishmaniasis caused by Leishmania (L.) infantum chagasi-infection. | Parasite | 2017 | https://conductscience.org/library/papers/29027520 | PubMed |
| 5 | 33139752 | Infection of dogs by Leishmania infantum elicits a general response of IgG subclasses. | Sci Rep | 2020 | https://conductscience.org/library/papers/33139752 | PubMed |
| 6 | 37569710 | A Tailored Approach to Leishmaniases Vaccination: Comparative Evaluation of the Efficacy and Cross-Protection Capacity of DNA vs. Peptide-Based Vaccines in a Murine Model. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569710 | PubMed |
| 7 | 23562649 | Asymptomatic dogs are highly competent to transmit Leishmania (Leishmania) infantum chagasi to the natural vector. | Vet Parasitol | 2013 | https://conductscience.org/library/papers/23562649 | PubMed |
| 8 | 32317026 | Latest trends in Leishmania infantum infection in dogs in Spain, Part I: mapped seroprevalence and sand fly distributions. | Parasit Vectors | 2020 | https://conductscience.org/library/papers/32317026 | PubMed |
| 9 | 37562277 | TLR-2 agonist Pam3CSK4 has no therapeutic effect on visceral leishmaniasis in BALB/c mice and may enhance the pathogenesis of the disease. | Immunobiology | 2023 | https://conductscience.org/library/papers/37562277 | PubMed |
| 10 | 29525281 | A large-scale field randomized trial demonstrates safety and efficacy of the vaccine LetiFend® against canine leishmaniosis. | Vaccine | 2018 | https://conductscience.org/library/papers/29525281 | PubMed |
| 11 | 31300103 | Strength and medium-term impact of HisAK70 immunization in dogs: Vaccine safety and biomarkers of effectiveness for ex vivo Leishmania infantum infection. | Comp Immunol Microbiol Infect Dis | 2019 | https://conductscience.org/library/papers/31300103 | PubMed |
| 12 | 31214607 | Assessment of Vaccine-Induced Immunity Against Canine Visceral Leishmaniasis. | Front Vet Sci | 2019 | https://conductscience.org/library/papers/31214607 | PubMed |
| 13 | 28114333 | Identification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine. | PLoS Negl Trop Dis | 2017 | https://conductscience.org/library/papers/28114333 | PubMed |
| 14 | 39355141 | Safety and efficacy of toll-like receptor agonists as therapeutic agents and vaccine adjuvants for infectious diseases in animals: a systematic review. | Front Vet Sci | 2024 | https://conductscience.org/library/papers/39355141 | PubMed |
| 15 | 19666153 | The chimerical multi-component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection. | Vaccine | 2009 | https://conductscience.org/library/papers/19666153 | PubMed |
| 16 | 31303211 | Canine visceral leishmaniasis biomarkers and their employment in vaccines. | Vet Parasitol | 2019 | https://conductscience.org/library/papers/31303211 | PubMed |
| 17 | 28242002 | Canine peripheral blood CD4+CD8+ double-positive Tcell subpopulations exhibit distinct Tcell phenotypes and effector functions. | Vet Immunol Immunopathol | 2017 | https://conductscience.org/library/papers/28242002 | PubMed |
| 18 | 22789871 | Canine CD4+CD8+ double positive T cells in peripheral blood have features of activated T cells. | Vet Immunol Immunopathol | 2012 | https://conductscience.org/library/papers/22789871 | PubMed |
| 19 | 29547503 | Parasite Specific Antibody Levels, Interferon-γ and TLR2 and TLR4 Transcripts in Blood from Dogs with Different Clinical Stages of Leishmaniosis. | Vet Sci | 2018 | https://conductscience.org/library/papers/29547503 | PubMed |
| 20 | 9431920 | Multicomponent chimeric antigen for serodiagnosis of canine visceral leishmaniasis. | J Clin Microbiol | 1998 | https://conductscience.org/library/papers/9431920 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41345965
GET https://conductscience.org/api/papers/v1/41345965/references?page=2